Nutex Health (NUTX) Operating Leases (2019 - 2026)

Nutex Health (NUTX) has 8 years of Operating Leases data on file, last reported at $29.6 million in Q1 2026.

• Quarterly Operating Leases fell 2.36% year-over-year to $29.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.6 million (down 2.36% YoY) and the FY2025 annual result came in at $30.0 million, down 1.89% from the prior year.
• Operating Leases fell to $29.6 million in Q1 2026 per NUTX's latest filing, from $30.0 million in the prior quarter.
• The five-year high for Operating Leases was $30.8 million in Q2 2025, with the low at $91238.0 in Q1 2022.
• Average Operating Leases over 5 years is $20.7 million, with a median of $19.4 million recorded in 2022.
• The widest YoY moves for Operating Leases: up 28291.31% in 2022, down 64.75% in 2022.
• Nutex Health's Operating Leases stood at $19.4 million in 2022, then retreated by 20.37% to $15.5 million in 2023, then soared by 97.79% to $30.6 million in 2024, then dropped by 1.89% to $30.0 million in 2025, then declined by 1.35% to $29.6 million in 2026.
• Business Quant data shows NUTX's Operating Leases at $29.6 million in Q1 2026, $30.0 million in Q4 2025, and $30.4 million in Q3 2025.